We have studied the effect of increasing concentrations of isoflurane on high-and low-affinity uptake of L-glutamate using synaptosomes from rat cerebral cortex. In the high-affinity uptake range, 0.5% isoflurane had no effect on uptake velocity, while 1.5% and 3.0% isoflurane caused an increase in mean Vmax to 131 (SEM 54) and 210 (103) % of control, respectively. There was no significant change in the K m value. Vmax and K m values for low-affinity uptake of L-glutamate were unchanged by 1.5% isoflurane. These results provide evidence for an isoflurane-induced increase in high-affinity uptake of glutamate into presynaptic terminals. This effect may contribute to a reduction of transmitter in the synaptic cleft and thereby decreased excitatory synaptic transmission. (Br.
As early as 1906, Sherrington reported that chloroform blocks reflex activity in the spinal cord at lower concentrations than those needed to inhibit impulse propagation along nerve fibres. 1 Later studies have shown that other inhalation agents depress excitatory synaptic transmission in the superior cervical ganglion 2 and in various parts of the central nervous system, including the spinal cord, 3 cuneate nucleus, 4 olfactory bulb, 5 olfactory cortex 6 7 and dentate area. 8 Isoflurane, a halogenated methyl-ethyl-ether, is used widely because of its advantages compared with older volatile anaesthetics. In the rat hippocampus, isoflurane inhibits excitatory signal transduction by depression of the activity in thin unmyelinated, afferent fibres, 9 reduction of excitatory synaptic transmission 10 11 and hyperpolarization of the postsynaptic neurone. 12 13 The effect on excitatory synaptic transmission seems quantitatively to be the most important. 10 14 Synaptic transmission may be depressed by druginduced reduction in the release of the transmitter from the presynaptic terminal, altered reuptake or reduced sensitivity of the postsynaptic receptor. Intracellular recordings from lumbosacral motor neurones in cats have shown that diethyl ether 15 depresses synaptic potentials, thus decreasing the amount of excitatory transmitter released while leaving the chemosensitivity of the postsynaptic membrane unchanged. We have shown recently that isoflurane reduced both synaptic (calcium-dependent) and non-synaptic (calcium-independent) potassiumstimulated release of glutamate from rat cerebral cortex, 16 without affecting the response on the postsynaptic membrane. 11 The effect on the presynaptic terminal may be caused by alteration in the uptake mechanism in addition to reduction in the release of transmitter.
To study further how isoflurane acts presynaptically, we have investigated the effect on neuronal reuptake mechanisms of glutamate using synaptosomes prepared from rat cerebral cortex.
Materials and methods

PREPARATION OF SYNAPTOSOMES
Synaptosomes were prepared, as described by McMahon and colleagues. 17 Briefly, Wistar rats, treated according to approved rules, were killed and the brain carefully removed. The cortex from each hemisphere was isolated and homogenized in 15 ml of sucrose 0.32 mol litre 91 (1-4 ЊC) using a glass homogenizer with a Teflon pestle (clearance:0.25 mm). The homogenate was centrifuged at 3000 g for 3 min and the supernatant spun at 15 000 g for 30 min. The pellet formed consisted of two layers. The superficial layer containing the majority of the synaptosomes 17 was resuspended selectively in 6 ml of sucrose 0.32 mol litre
91
, stored at 1-4 ЊC and used within 6 h from preparation. The pellet was diluted before use in HEPES-buffered medium (HBM) containing (mmol litre ) (Amersham Laboratories, Buckinghamshire, UK) was added to each L-glutamate concentration. The chambers, each containing 1.5 ml of incubation medium, were sealed and saturated with 95% oxygen-5% carbon dioxide. Isoflurane 0.5, 1.5 or 3.0% (Abbot Laboratories Ltd., Kent, UK) was added using a vaporizer (Fortec, Ohmeda 5250 RGM, Englewood, USA) and the medium shaken gently every 30 s. Uptake was terminated at 4 min as the synaptosomes were placed on a Millipore filter (0.65 mm), washed in 5 ml of 0.9% NaCl (1-4 ЊC) and dissolved in 1 ml of 10% Triton X-100 (toctylphenoxypolyethoxyethanol) (Sigma Chemical Co., St Louis, MO, USA) for 10 min. The suspension was then removed from the filter before scintillation fluid (Pico-Fluor 15, Packard, Groningen, The Netherlands) was added. The labelling was measured by counting disintegrations per minute in a ␤-scintillation counter (LKB Wallac, San Fransisco, CA, USA) with a counting efficiency of 25-30%. Protein content was measured using the method of Lowry and colleagues. 19 In each setting, a control experiment and experiments using 0.5, 1.5 and 3.0% isoflurane were performed using one batch of synaptosomes from one brain. The number of experiments (n:9) thus reflects the number of rats used.
Results are presented as mean (SEM). Differences between the two groups were tested using the Wilcoxon signed rank sum test and for three or more groups with the Kruskal-Wallis test. Differences were considered significant when P:0.05.
Results
In the first set of experiments, concentrations of Lglutamate were increased from 0.55 10 95 to 2.5 10 95 mol litre 91 corresponding to the highaffinity uptake system with a reported K m value of 0.2-5.0 10 95 mol litre
91
. 18 20 Uptake velocity for Lglutamate was measured in the control situation and under the influence of isoflurane in increasing concentrations (0.5, 1.5 and 3.0%). The results are summarized in table 1. By plotting the mean values from table 1 in a double reciprocal plot (Lineweaver-Burk plot) as shown in figure 1, straight lines with regression coefficients (r 2 ) of 0.905 to 0.992 were drawn. Vmax and K m were calculated from the intercepts of the lines on the Y and X axis, respectively. The lowest concentration, 0.5% isoflurane, had no effect on uptake velocity as the control and 0.5% isoflurane plots were parallel. However, 1.5 and 3.0% isoflurane produced an increase in uptake velocity, as seen from the reduced steepness of the plot in figure 1 . As all lines cross the X axis at approximately the same point, the highaffinity transporter to glutamate was presumably unaffected by isoflurane.
Calculated K m and Vmax values for the highaffinity uptake system are presented in , and there was no significant change in response to 0.5% isoflurane. However, 1.5 and 3.0% isoflurane increased Vmax to 1.97 (0.80) and 3.09 (1.52) mol g 91 min
, respectively (P:0.05), corresponding to 131% and 210% increases, on average, K m for the high-affinity transporter was 52.9 (50.2) mol litre 91 . Isoflurane 0.5, 1.5 and 3.0% had no effect on K m .
In the second set of experiments the effect of isoflurane on the low-affinity uptake system was investigated, using glutamate concentrations from 1 10 94 to 1 10 93 mol litre
. The double reciprocal plot in ) at different concentrations of L-glutamate in the high affinity range in the synaptosomal fraction from rat cerebral cortex. The effects of 0.5, 1.5 and 3.0% isoflurane were tested (mean (SEM), n:9). figure 2 describes a straight line with a regression coefficient of 0.904. As 0.5% isoflurane had no effect on the high-affinity uptake system, 1.5% isoflurane, which corresponds to approximately 1 MAC (minimal alveolar concentration), was tested. As is evident from figure 2, showing almost identical plots during control and isoflurane administration, 1.5% isoflurane had no effect on uptake velocity. Vmax for the low-affinity uptake system was calculated as 16.3 (11.9) mol g 91 min
, and 1.5% isoflurane had no effect on Vmax. The calculated K m value for the lowaffinity uptake system was 1.0 (0.9) mmol litre
. K m was unaffected by 1.5% isoflurane.
Discussion
Volatile anaesthetics seem to exert their effects in the central nervous system by affecting several different sites, including both excitatory and inhibitory pathways; for example isoflurane affects conduction in unmyelinated fibres, excitatory synaptic transmission, membrane properties of the postsynaptic neurone and inhibitory synaptic transmission. 9 11 12 21 However, the quantitatively most important effect is probably decreased excitatory synaptic transmission 10 which can be caused by decreased amount of transmitter released from the presynaptic terminal, more efficient reuptake from the synaptic cleft or reduced sensitivity of the postsynaptic membrane. This study showed an anaesthetic-induced increase in the uptake velocity of transmitter glutamate presynaptically. Taken together with the previously demonstrated decrease in transmitter release, 16 increased uptake further attenuates the excitatory synaptic transmission by faster termination of transmitter action.
The synaptosomal preparation used in this study is a mixture of pinched off nerve endings and to a large extent free from glial cells and cell debris. 22 The preparation consists of sealed plasma membrane vesicles with preserved release and uptake mechanisms. 23 Synaptosomes from rat cerebral cortex exhibit both high-and low-affinity uptake mechanisms for glutamate 18 and a high-affinity uptake system for ␥-aminobutyric acid. 23 Because of well functioning secretory and uptake mechanisms, the method is regarded as well suited for studying neuronal release and uptake mechanisms of transmitters. 20 Both neurones and glial cells have uptake systems important in terminating the effect of transmitter glutamate in the synaptic cleft. 20 We have demonstrated uptake systems both in low-and high-affinity areas with K m values of approximately 1 mmol litre 91 and 50 mol litre
91
, respectively. These are in agreement with previous reports of two different uptake systems in rat cortical synaptosomes, one in the lowaffinity area with a K m value of approximately 1 mmol litre 91 and the other in the high-affinity area with a K m value of 2-50 mol litre
. 18 24 The physiological role of the low-affinity transporter is still unclear although it has been suggested that it prevents peak concentrations of extracellular glutamate. 25 The high-affinity uptake system, which is active in glial cells and in glutamatergic neurones, is important in terminating transmitter action. 25 The mechanisms that regulate these transporter proteins are not fully understood. Four different glutamate transporters have recently been identified and cloned in human brain. 25 26 EAAT 1 (excitatory amino acid transporter) is localized only in the plasma membrane of glial cells, EAAT 2 in neurones and glial cells, EAAT 3 in neuronal plasma membranes 27 and EAAT 4 predominantly in cerebellum. 26 EAAT 1 is activated as protein kinase C (PKC) catalyses phosphorylation of the transporter protein. 28 In cultures of glial cells, stimulation of PKC activity with phorbol esters increases the highaffinity transport of L-glutamate seen as increased Vmax whereas K m is unaltered. 29 PKC stimulation also enhanced Vmax, but not K m , of a cloned ␥-aminobutyric acid transporter in Xenopus oocytes through translocation of the transporter from a cytoplasmic compartment to the plasma membrane. 30 Several volatile anaesthetics, including halothane and to some extent isoflurane, increase PKCmediated phosphorylation of several rat brain cytoplasmic proteins in a calcium-and phospholipiddependent manner. 31 One of these proteins, a major substrate for PKC, might have a regulatory role in neurotransmission. 31 As halothane and enflurane appear to inhibit PKC itself, 32 potential targets for anaesthetic action in intact neurones could be complex processes leading to release of intracellular calcium or production of diacylglycerol, which are both required for PKC activation. Furthermore, experimental observations have indicated that neurones may release factors that influence the activity of glutamate and GABA transporters in glial cells and thus suggest an alternative mechanism of action for anaesthetic agents. 33 The potency of inhaled anaesthetics is described as the minimum alveolar concentration (MAC) of the gas producing surgical anaesthesia in 50% of subjects. The MAC value for isoflurane in middleaged humans is 1.15% and for rats, 1.38%, and does not alter with increasing duration of anaesthesia. Concentrations exceeding 1 MAC are needed to depress the electroencephalogram (EEG) and at 2 MAC the EEG becomes isoelectric. 34 In this study, isoflurane was added to the incubation chambers in clinically relevant doses. The chambers were sealed in order to minimize gas leakage. If a small leakage should occur, however, the effect of the anaesthetic would occur at lower concentrations and the effect would thus be underestimated.
Isoflurane (0.5, 1.5 and 3.0%) increased highaffinity uptake of glutamate. A possible explanation could be an anaesthetic-induced increase in PKC activity catalysing phosphorylation and thereby activation of the transporter protein. This is in agreement with the previously mentioned activation of EAAT 1 in glial cells by PKC, 28 29 35 causing increased uptake velocity. Furthermore, this is in agreement with studies where halothane, and to some extent isoflurane, enhanced PKC activity on brain cytoplasmic proteins. 31 According to these observations, halothane and isoflurane can upregulate glutamate uptake through PKC-mediated activation of the transporter protein located on the presynaptic plasma membrane or induce translocation of transporters from the cytosol to the plasma membrane. This would subsequently reduce the amount of transmitter available for the postsynaptic membrane and restrict the time the transmitter is available in the synaptic cleft.
In this study, we have demonstrated that 1.5 and 3.0% isoflurane increased the uptake velocity in a dose-dependent manner. Isoflurane thus reduced excitatory synaptic transmission by reducing the amount of transmitter in the synaptic cleft.
